Collaborating Across the Extended Pharmaceutical Enterprise: How Sharing Information Leads to Process Enablement

by Peter Loupos, Aventis Drug Innovation and Approval and Andrew Grygiel A collaborative framework can be a driver for cultural change, encouraging knowledge sharing between internal and external personnel and improving innovation and productivity throughout the enterprise.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Guest Interview: A Strong Dose of Reality: Visiting with Cynthia Robbins-Roth

Sialylation Levels Influence Oligosaccharide Quantitation: Analyzing Response Variability Using High-pH Anion-Exchange Chromatography and Pulsed Amperometric Detection

SOX in the Boardroom: What the Sarbanes?Oxley Act Means to You

The Project Management Institute's Pharmaceutical Specific Interest Group 2002 Benchmark Survey Results: Project Managers and Project Management in the Biotech Industry

Small Biopharms Face Unique Challenges: Outsourcing in Early-Stage Drug Development

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Collaborating Across the Extended Pharmaceutical Enterprise: How Sharing Information Leads to Process Enablement

Newsletter